Bank of America’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Bank of America’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-796,277	Closed	-$13.4M	–	8154
2023 Q2	$13.4M	Buy	796,277 +756,536	+1,904%	+$9.94M	﹤0.01%	2411
2023 Q1	$338K	Buy	39,741 +35,353	+806%	+$291K	﹤0.01%	5629
2022 Q4	$38K	Buy	4,388 +2,187	+99%	+$17.6K	﹤0.01%	6567
2022 Q3	$13K	Buy	2,201 +2,200	+220,000%	+$11.9K	﹤0.01%	7175
2022 Q2	$0	Sell	1 -85,483	-100%	-$460K	﹤0.01%	8632
2022 Q1	$403K	Buy	85,484 +12,802	+18%	+$66.9K	﹤0.01%	5985
2021 Q4	$357K	Buy	72,682 +72,005	+10,636%	+$355K	﹤0.01%	6135
2021 Q3	$5K	Buy	677 +676	+67,600%	+$5.79K	﹤0.01%	7749
2021 Q2	$0	Buy	+1	New	+$15	﹤0.01%	8247

Other funds holding VECT

RCM

Regency Capital Management Honolulu, Hawaii $224M AUM 26.03% 1-Year Est. Return

SOW

State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return

Bank of America's VECT Position: Q3 2023 in Review

Bank of America sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q3 2023, closing a stake of 796,277 shares — an estimated $13.4M sold.

Bank of America first reported a position in VECT in Q2 2021 and held it in 9 quarters. The position peaked at $13.4M in Q2 2023. 2 funds tracked by Wall St. Rank hold VECT as of Q3 2023.

Bank of America reported no remaining VectivBio Holding AG Ordinary Shares position as of Q3 2023 after selling out during the quarter.
Bank of America sold 796,277 VectivBio Holding AG Ordinary Shares shares in Q3 2023, an estimated $13.4M.
Bank of America first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 9 quarters.
Bank of America's VectivBio Holding AG Ordinary Shares position peaked at $13.4M in Q2 2023.
2 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q3 2023.

Based on Bank of America's 13F filing for Q3 2023, filed 14 Nov 2023.